Physician profile
Angel J Torres
NPI 1235155573
$3,085.76
in general payments reported to CMS, 2019-2025
11 companies · $500 in 2025
The $500 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $12.88 · 2022: $23.17 · 2023: $252 · 2024: $2,298 · 2025: $500.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,775 · Food and Beverage: $275.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,775.00 |
| Food and Beverage | $274.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tandem Diabetes Care, INC. | $2,775.00 | 2024-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Pfizer INC. | $60.44 | 2021-2024 | |
| Astrazeneca Pharmaceuticals Lp | $60.34 | 2023 | Flumist Quadrivalent |
| Novo Nordisk INC | $59.90 | 2023 | Wegovy, Rybelsus, Ozempic |
| Abbvie INC. | $23.17 | 2022 | |
| Shield Therapeutics INC | $19.02 | 2023 | Accrufer |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.75 | 2023 | |
| Idorsia Pharmaceuticals US INC | $18.41 | 2023 | Quviviq |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.65 | 2023 | Xifaxan |
| Medtronic, INC. | $17.63 | 2023 | Intellis Adaptivestim |
| Exact Sciences Corporation | $15.45 | 2023 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angel Torres listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.